Brief: Mayne Pharma Group Updates On Status Of FIRB Approval
07/11/2025 01:40
Nov 7 (Reuters) - Mayne Pharma Group Ltd MYX.AX: UPDATE ON STATUS OF FIRB APPROVAL FIRB EXTENDS DEADLINE FOR APPROVAL TO 14 NOVEMBER 2025 Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)